Clinical Trial Update: The Efficacy of TROP2-ADC in Advanced Extrapulmonary High-Grade Neuroendocrine Neoplasms Failure of Standard Therapy [Phase 2]

View source ↗

Summary

This document reports a Phase 2 clinical trial evaluating a Trop2-targeting antibody-drug conjugate (TROP2-ADC) in advanced extrapulmonary high-grade neuroendoc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroendocrine Neoplasms

Drugs mentioned

• Trop2 ADC

Snippet

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: Neuroendocrine Neoplasms (Tumours) | Phase 2 | Status: NOT_YET_RECRUITING